Ciprofloxacin DPI: a randomised, placebo-controlled, phase IIb efficacy and safety study on cystic fibrosis

BACKGROUND: Treatment of infective bronchitis involving Pseudomonas aeruginosa is a cornerstone of care in patients with cystic fibrosis (CF). This phase IIb, randomised, double-blind, placebo-controlled study assessed the efficacy and safety of ciprofloxacin dry powder for inhalation (DPI) in this...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Open Respir Res
Main Authors: Dorkin, Henry L, Staab, Doris, Operschall, Elisabeth, Alder, Jeff, Criollo, Margarita
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2015
Assuntos:
Cystic Fibrosis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4680008/
https://ncbi.nlm.nih.gov/pubmed/26688732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjresp-2015-000100
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados